Get access

Lexipafant for acute pancreatitis

  • Protocol
  • Intervention

Authors

  • Xunzhe Yang,

    1. West China Hospital, Sichuan University, Chengdu, Sichuan, China
    Search for more papers by this author
  • Xiaoxi Zeng,

    1. West China Hospital, Sichuan University, Chengdu, Sichuan, China
    Search for more papers by this author
  • Taixiang Wu

    Corresponding author
    1. West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, Chengdu, Sichuan, China
    • Taixiang Wu, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the therapeutic potential of lexipafant: whether it can alter the course of the disease, prevent or treat organ failure, and reduce mortality in acute pancreatitis.

Get access to the full text of this article